• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

    3/20/24 2:03:46 PM ET
    $ADVM
    $AISP
    $ANGH
    $ANVS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Computer Software: Prepackaged Software
    Technology
    Get the next $ADVM alert in real time by email

    Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and board changes.

    Lifecore Biomedical shares dipped 31.7% to $4.91 on Wednesday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • ETAO International Co., Ltd. (NASDAQ:ETAO) shares shot up 111.5% to $0.3025. The company announced a reverse stock split.
    • XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB) gained 74.3% to $1.7950 after the company announced plans to acquire The Social Proxy.
    • TruGolf Holdings, Inc. (NASDAQ:TRUG) shares climbed 56% to $1.7938 after the company announced a newly expanded AI technology licensing agreement with mlSpatial.
    • Treasure Global Inc. (NASDAQ:TGL) climbed 39% to $6.09.
    • Anghami Inc. (NASDAQ:ANGH) gained 37% to $1.3703.
    • Oblong, Inc. (NASDAQ:OBLG) rose 30.7% to $0.1765 after the company reported financial results for fourth quarter 2023 and issued a business update.
    • SCWorx Corp. (NASDAQ:WORX) rose 27% to $3.6061 after surging around 54% on Tuesday.
    • Edgio, Inc. (NASDAQ:EGIO) gained 26% to $8.79.
    • Annovis Bio, Inc. (NASDAQ:ANVS) gained 25.6% to $11.21 after the company announced the completion of data cleaning for its Phase 2/3 study of Buntanetap in patients with mild to moderate Alzheimer's disease, with Topline efficacy data expected in April.
    • Taysha Gene Therapies, Inc. (NASDAQ:TSHA) rose 23% to $2.7650 after the company reported a year-over-year increase in FY23 EPS results.
    • Cemtrex, Inc. (NASDAQ:CETX) jumped 22% to $4.31.
    • Swvl Holdings Corp. (NASDAQ:SWVL) rose 19.7% to $10.16.
    • Brenmiller Energy Ltd (NASDAQ:BNRG) gained 19% to $2.94.
    • CareMax, Inc. (NASDAQ:CMAX) climbed 18.4% to $5.80.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) gained 18.1% to $43.00.
    • TeraWulf Inc. (NASDAQ:WULF) jumped 18% to $2.0297 amid a rise in Bitcoin.
    • Blade Air Mobility, Inc. (NASDAQ:BLDE) rose 17.1% to $2.87 after the company announced a $20 million share repurchase program.
    • Canopy Growth Corporation (NASDAQ:CGC) gained 15% to $4.4056. VP Kamala Harris recently urged the DEA to reschedule marijuana.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) surged 12.4% to $10.25.
    • Iris Energy Limited (NASDAQ:IREN) gained 11.3% to $5.00.
    • Sportradar Group AG (NASDAQ:SRAD) climbed 10.7% to $11.17 after the company reported better-than-expected fourth-quarter results and authorized a $200 million share repurchase program.
    • BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) climbed 10% to $0.0220 after falling 15% on Tuesday. Aegis Capital acted as Sole bookrunner on a $7.0 million underwritten public offering for BYND Cannasoft Enterprises Inc.
    • The Beauty Health Company (NASDAQ:SKIN) gained 9.3% to $4.3050.
    • Marathon Digital Holdings, Inc. (NASDAQ:MARA) jumped 7.5% to $20.77 amid a rise in Bitcoin.
    • Spirit AeroSystems Holdings, Inc. (NYSE:SPR) gained 6.7% to $35.19.

    Losers

    • NuScale Power Corporation (NYSE:SMR) shares tumbled 28% to $4.73. NuScale Power shares dipped around 35% on Tuesday after Wells Fargo downgraded the stock from Equal-Weight to Underweight and lowered its price target from $7.50 to $4.50.
    • Ontrak, Inc. (NASDAQ:OTRK) dipped 26% to $0.3258 after jumping over 131% on Tuesday.
    • Momentus Inc. (NASDAQ:MNTS) fell 21.7% to $0.4647, reversing after spiking 17% on Tuesday following a US patent grant.
    • Aterian, Inc. (NASDAQ:ATER) dipped 21.3% to $0.26. Aterian announced a reverse stock split.
    • Aquestive Therapeutics, Inc. (NASDAQ:AQST) fell 15.4% to $4.51. Aquestive Therapeutics priced its $75 million underwritten public offering of 16,666,667 common shares at $4.50 per share.
    • Aptorum Group Limited (NYSE:APM) declined 14.8% to $8.20.
    • Airship AI Holdings, Inc. (NASDAQ:AISP) fell 14.8% to $10.88.
    • Seelos Therapeutics, Inc. (NASDAQ:SEEL) dipped 14.6% to $0.5550. Seelos Therapeutics recently announced that its ALS study with SLS-005 did not meet statistical significance in the primary and secondary endpoint in the Full Analysis Set.
    • Astria Therapeutics, Inc. (NASDAQ:ATXS) fell 13.3% to $14.47.
    • Signet Jewelers Limited (NYSE:SIG) declined 11% to $91.20 after the company reported worse-than-expected fourth-quarter sales and issued weak FY25 guidance.
    • Mercurity Fintech Holding Inc. (NYSE:MFH) fell 10.7% to $1.41.
    • Harrow, Inc. (NASDAQ:HROW) fell 8.6% to $9.73 after posting weaker-than-expected fourth-quarter results.
    • Sotera Health Company (NASDAQ:SHC) dipped 8.8% to $11.96.
    • Adverum Biotechnologies, Inc. (NASDAQ:ADVM) fell 7.8% to $1.52.
    • BioNTech SE (NASDAQ:BNTX) fell 6.3% to $88.24 after the company reported worse than expected fourth-quarter FY23 earnings and issued FY2024 guidance.

     

    Now Read This: Bitcoin Tops $64,000 Ahead Of Fed's Decision; Pepe Emerges As Top Gainer

    Get the next $ADVM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADVM
    $AISP
    $ANGH
    $ANVS

    CompanyDatePrice TargetRatingAnalyst
    Canopy Growth Corporation
    $CGC
    3/27/2026Buy
    Canaccord Genuity
    TeraWulf Inc.
    $WULF
    3/23/2026$30.00Buy
    Arete
    Lifecore Biomedical Inc.
    $LFCR
    3/17/2026$5.50Mkt Perform → Outperform
    Barrington Research
    MARA Holdings Inc.
    $MARA
    2/27/2026Buy → Neutral
    H.C. Wainwright
    NuScale Power Corporation
    $SMR
    2/27/2026$21.00Market Perform → Outperform
    Northland Capital
    NuScale Power Corporation
    $SMR
    2/11/2026Buy → Hold
    TD Cowen
    TeraWulf Inc.
    $WULF
    2/9/2026$37.00Overweight
    Morgan Stanley
    MARA Holdings Inc.
    $MARA
    2/9/2026$8.00Underweight
    Morgan Stanley
    More analyst ratings

    $ADVM
    $AISP
    $ANGH
    $ANVS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bucella Michael C. bought $19,950 worth of shares (1,338 units at $14.91), increasing direct ownership by 0.49% to 273,552 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    3/13/26 5:49:13 PM ET
    $WULF
    EDP Services
    Technology

    Director Bucella Michael C. bought $30,071 worth of shares (2,085 units at $14.42), increasing direct ownership by 0.77% to 272,214 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    3/9/26 7:31:19 PM ET
    $WULF
    EDP Services
    Technology

    Director Bucella Michael C. bought $50,038 worth of shares (3,171 units at $15.78), increasing direct ownership by 1% to 270,129 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    3/4/26 5:34:43 PM ET
    $WULF
    EDP Services
    Technology

    $ADVM
    $AISP
    $ANGH
    $ANVS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Canopy Growth

    Canaccord Genuity initiated coverage of Canopy Growth with a rating of Buy

    3/27/26 8:46:41 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Arete initiated coverage on TeraWulf with a new price target

    Arete initiated coverage of TeraWulf with a rating of Buy and set a new price target of $30.00

    3/23/26 8:29:37 AM ET
    $WULF
    EDP Services
    Technology

    Lifecore Biomedical upgraded by Barrington Research with a new price target

    Barrington Research upgraded Lifecore Biomedical from Mkt Perform to Outperform and set a new price target of $5.50

    3/17/26 7:45:07 AM ET
    $LFCR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $AISP
    $ANGH
    $ANVS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Tilzer Brian A

    4 - SIGNET JEWELERS LTD (0000832988) (Issuer)

    3/26/26 4:43:11 PM ET
    $SIG
    Consumer Specialties
    Consumer Discretionary

    SEC Form 4 filed by Cho Karen Leslie

    4 - SIGNET JEWELERS LTD (0000832988) (Issuer)

    3/26/26 4:43:06 PM ET
    $SIG
    Consumer Specialties
    Consumer Discretionary

    SEC Form 4 filed by Ciccolini Vincent

    4 - SIGNET JEWELERS LTD (0000832988) (Issuer)

    3/26/26 4:43:01 PM ET
    $SIG
    Consumer Specialties
    Consumer Discretionary

    $ADVM
    $AISP
    $ANGH
    $ANVS
    SEC Filings

    View All

    Harrow Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    8-K - HARROW, INC. (0001360214) (Filer)

    3/27/26 4:05:13 PM ET
    $HROW
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 20-F filed by Aptorum Group Limited

    20-F - Aptorum Group Ltd (0001734005) (Filer)

    3/27/26 4:02:32 PM ET
    $APM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by TeraWulf Inc.

    SCHEDULE 13G/A - TERAWULF INC. (0001083301) (Subject)

    3/27/26 1:32:18 PM ET
    $WULF
    EDP Services
    Technology

    $ADVM
    $AISP
    $ANGH
    $ANVS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Canopy Growth Announces Storz & Bickel Executive Transition

    David Männer appointed Managing Director Jürgen Bickel, who co-founded and built Storz & Bickel into a global premium vaporization technology leader, passes the torch following 25 years of transformational leadership Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced the appointment of David Männer as Managing Director of Storz & Bickel, a subsidiary of Canopy Growth, effective April 1, 2026. Mr. Männer succeeds Jürgen Bickel, Storz & Bickel's Co-founder, who has decided to transition out of his role. Founded in 2001, Storz & Bickel has grown into a global leader in vaporization technology. Today, it sets the standard for innovation, p

    3/27/26 7:30:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Sportradar Files Its Annual Report on Form 20-F

    ST. GALLEN, Switzerland, March 27, 2026 (GLOBE NEWSWIRE) -- Sportradar Group AG (NASDAQ:SRAD) (the "Company") today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the Securities and Exchange Commission on March 27, 2026. The annual report on Form 20-F can be accessed on the Company's investor relations website at https://investors.sportradar.com/financials-filings/sec-filings or on the SEC's website at www.sec.gov. The Company will provide a paper copy of the annual report containing its audited consolidated financial statements, free of charge, to its shareholders upon request. Requests should be directed in writing by email to in

    3/27/26 7:05:00 AM ET
    $SRAD
    Computer Software: Programming Data Processing
    Technology

    Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    CHASKA, Minn., March 26, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:LFCR) ("Lifecore") a fully integrated injectables contract development and manufacturing organization ("CDMO"), today announced that effective on March 25, 2026, Lifecore granted a restricted stock unit ("RSU") award with respect to 18,500 shares of its common stock under Lifecore's Equity Inducement Plan, as amended (the "Inducement Plan") to a newly hired employee of Lifecore. The RSU award was granted pursuant to the offer letter between Lifecore and the employee, and as a material inducement to the employee joining Lifecore. The RSU award was approved by Lifecore's compensation committee and was grante

    3/26/26 4:05:00 PM ET
    $LFCR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $AISP
    $ANGH
    $ANVS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for LIBERVANT issued to AQUESTIVE THERAPEUTICS INC

    Submission status for AQUESTIVE THERAPEUTICS INC's drug LIBERVANT (ORIG-1) with active ingredient DIAZEPAM has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218623, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    4/29/24 7:48:13 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $AISP
    $ANGH
    $ANVS
    Leadership Updates

    Live Leadership Updates

    View All

    Canopy Growth Announces Storz & Bickel Executive Transition

    David Männer appointed Managing Director Jürgen Bickel, who co-founded and built Storz & Bickel into a global premium vaporization technology leader, passes the torch following 25 years of transformational leadership Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced the appointment of David Männer as Managing Director of Storz & Bickel, a subsidiary of Canopy Growth, effective April 1, 2026. Mr. Männer succeeds Jürgen Bickel, Storz & Bickel's Co-founder, who has decided to transition out of his role. Founded in 2001, Storz & Bickel has grown into a global leader in vaporization technology. Today, it sets the standard for innovation, p

    3/27/26 7:30:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer

    Thomas A. Zalewski, a Partner at Day Pitney LLP, appointed Chief Legal Officer and Chief Compliance Officer effective April 2, 2026Lori J. Braender to remain in a non-executive role as Corporate Secretary after nearly eight years as Chief Legal Officer, Chief Compliance Officer and Corporate Secretary WARREN, N.J., March 20, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced the appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer, effective Apr

    3/20/26 7:00:00 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Canopy Growth Completes Acquisition of MTL Cannabis Creating Canada's Leading Medical Cannabis Business By Revenue

    This news release constitutes a "designated news release" for the purposes of Canopy Growth's prospectus supplement dated August 29, 2025 to its short form base shelf prospectus dated June 5, 2024 All financial amounts in this press release are expressed in Canadian dollars. Strengthens Canopy Growth's core Canadian platform, providing additional high-quality flower to support international growth Expected run-rate synergies of approximately $10 million within 18 months Canopy Growth's leadership team and operational depth strengthened through addition of MTL management team members Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) and MTL Cannab

    3/16/26 7:41:00 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    $ADVM
    $AISP
    $ANGH
    $ANVS
    Financials

    Live finance-specific insights

    View All

    Aterian Provides Update on Strategic Alternatives Process

    SUMMIT, N.J., March 23, 2026 (GLOBE NEWSWIRE) -- Aterian, Inc. (NASDAQ:ATER) ("Aterian" or the "Company"), a consumer products company, today provided the following update on its previously announced Strategic Alternative Process. "Our Strategic Alternative Process is progressing well since our first announcement in December 2025. We continue to engage in constructive discussions regarding potential strategic alternatives and are making progress in evaluating opportunities. We are guided in this initiative by our continued belief that our current market valuation simply does not reflect the sum-of-the-parts value of our brand portfolio. We continue to approach this review thoughtfully and

    3/23/26 8:30:00 AM ET
    $ATER
    Home Furnishings
    Consumer Discretionary

    Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update

    Dosed multiple Rett syndrome patients in REVEAL pivotal trial of TSHA-102, with enrollment advancing across multiple sites; on track to complete dosing in Q2 2026 Received FDA clearance to initiate ASPIRE trial in three patients aged 2 to <4 years with inclusion of ≥3 months of safety data in planned BLA submission to support potential for broad label; on track to complete dosing in Q2 2026 Maintained favorable tolerability profile with no treatment-related SAEs or DLTs in REVEAL Phase 1/2 and REVEAL pivotal trials as of March 2026 data cutoff; longer-term safety and efficacy data from Part A of REVEAL Phase 1/2 trials expected in Q2 2026 Reached written alignment with FDA on proposed PPQ

    3/19/26 8:00:00 AM ET
    $TSHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Signet Jewelers Reports Fourth Quarter and Full Year Fiscal 2026 Results

    Introduces Fiscal 2027 Guidance Increases Dividend to $0.35 per share Signet Jewelers Limited ("Signet" or the "Company") (NYSE:SIG) today announced its results for the 13 and 52 weeks ended January 31, 2026 ("fourth quarter Fiscal 2026" and "full year Fiscal 2026", respectively). "FY26 delivered over a point of comp growth driven by heightened focus on our three largest brands – Kay, Zales, and Jared. Building on that momentum, FY27 will focus on accelerating core performance through sharper brand differentiation, broader customer reach, and a more seamless in‑store and digital experience. As we continue to advance our Grow Brand Love strategy into its second year, we expect to furth

    3/19/26 6:50:00 AM ET
    $SIG
    Consumer Specialties
    Consumer Discretionary

    $ADVM
    $AISP
    $ANGH
    $ANVS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Blade Air Mobility Inc.

    SC 13G/A - Blade Air Mobility, Inc. (0001779128) (Subject)

    12/10/24 1:28:44 PM ET
    $BLDE
    Transportation Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Harrow Inc.

    SC 13G/A - HARROW, INC. (0001360214) (Subject)

    12/5/24 7:08:52 PM ET
    $HROW
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Brenmiller Energy Ltd

    SC 13D/A - Brenmiller Energy Ltd. (0001901215) (Subject)

    12/5/24 11:18:20 AM ET
    $BNRG
    Building Products
    Industrials